NCT04124003View on ClinicalTrials.gov

A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions
Healthy Participants
Interventions
DRUG

rosuvastatin

Specified dose on specified days

DRUG

BMS-963272

Specified dose on specified days

Trial Locations (1)

84124

PRA Health Sciences - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04124003 - A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin | Biotech Hunter | Biotech Hunter